Safety and efficacy of tocilizumab for rheumatoid arthritis: a systematic review and metaanalysis of clinical trial studies

Código QR

Safety and efficacy of tocilizumab for rheumatoid arthritis: a systematic review and metaanalysis of clinical trial studies

The present systematic review and meta-analysis was conducted to assess the effect of tocilizumab (TCZ) in patients with rheumatoid arthritis (RA). We systematically searched all potential articles in the main databases, including PubMed, Scopus, EMBASE, Web of Sciences (ISI), and Cochrane Center. T...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Amal Saki, Elham Rajaei, Fakher Rahim
Formato:	article
Lenguaje:	EN
Publicado:	Termedia Publishing House 2021
Materias:	adverse events efficacy safety meta-analysis rheumatoid arthritis tocilizumab. Medicine R
Acceso en línea:	https://doaj.org/article/1732af7b3ed2409c9ee8972c9cb252ea
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Tocilizumab in refractory rheumatoid arthritis: long-term efficacy, safety, and tolerability beyond 2 years
por: Farah Z, et al.
Publicado: (2016)

Nivolumab-induced new-onset seronegative rheumatoid arthritis in a patient with advanced metastatic melanoma: A case report and literature review
por: Ammar Haikal, et al.
Publicado: (2018)

Dynamic Contrast-Enhanced MRI Confirms Rapid And Sustained Improvement Of Rheumatoid Arthritis Induced By Tocilizumab Treatment: An Italian Multicentre Study
por: Cimmino MA, et al.
Publicado: (2020)

Retrospective analyzes of adverse events during biologic agents in children with juvenile idiopathic arthritis from a single center in Turkey
por: Sibel Balcı, et al.
Publicado: (2020)

Patient-Reported Questionnaires to Identify Adverse Drug Reactions: A Systematic Review
por: Renly Lim, et al.
Publicado: (2021)

Present day therapy of juvenile idiopathic arthritis with the use of genetically engineered medicines in a third level regional hospital - results and problems
por: A. E. Matyunova, et al.
Publicado: (2017)

Safety findings from CENTURION, a phase 3 consistency study of lasmiditan for the acute treatment of migraine
por: C Tassorelli, et al.
Publicado: (2021)

Pooled safety analysis of diclofenac sodium topical solution 1.5% (w/w) in the treatment of osteoarthritis in patients aged 75 years or older
por: Roth SH, et al.
Publicado: (2012)

Review: A Safety Profile of Dalbavancin for On- and Off-Label Utilization
por: Simonetti O, et al.
Publicado: (2021)

A Single-Center Retrospective Observational Study Evaluating the Favorable Predictive Factors for the Disease Control Time of Treatment with Tocilizumab in Patients of Rheumatoid Arthritis
por: Ishii N, et al.
Publicado: (2021)

The More, the Merrier…? Antipsychotic Polypharmacy Treatment Strategies in Schizophrenia From a Pharmacology Perspective
por: Stephan Hjorth, et al.
Publicado: (2021)

Thrombotic Events after COVID-19 Vaccination in the Over-50s: Results from a Population-Based Study in Italy
por: Ileana Baldi, et al.
Publicado: (2021)

Consecuencias adversas inesperadas durante el uso de antimicrobianos: Cuándo el tratamiento puede ser peligroso para la salud
por: WOLFF R.,MARCELO
Publicado: (2002)

Efficacy and safety of various anti-rheumatic treatments for patients with rheumatoid arthritis: a network meta-analysis
por: Kexun Ma, et al.
Publicado: (2018)

Efficacy and Treatment-Related Adverse Events of Romidepsin in PTCL Clinical Studies: A Systematic Review and Meta-Analysis
por: Jun Du, et al.
Publicado: (2021)

Rheumatoid arthritis hand lesions assessed with outcome measures in rheumatoid arthritis clinical trials-rheumatoid arthritis magnetic resonance imaging score – proposing an extended rheumatoid arthritis magnetic resonance imaging score
por: M. del Carmen Larios-Forte, et al.
Publicado: (2021)

Pharmacogenetics to Avoid Adverse Reactions in Cardiology: Ready for Implementation?
por: Xandra García-González, et al.
Publicado: (2021)

Prevalence and Quality of Informed Consent for Patients Undergoing Cosmetic Procedures: A Cross Sectional Study
por: Saud Alsaidan,Mohammed, et al.
Publicado: (2021)

Tocilizumab in Systemic Juvenile Idiopathic Arthritis: Response Differs by Disease Duration at Medication Initiation and by Phenotype of Disease
por: Xin Yan, et al.
Publicado: (2021)

A Network Comparison on Safety Profiling of Immune Checkpoint Inhibitors in Advanced Lung Cancer
por: Yi-Dan Yan, et al.
Publicado: (2021)

Thrombotic Adverse Events Reported for Moderna, Pfizer and Oxford-AstraZeneca COVID-19 Vaccines: Comparison of Occurrence and Clinical Outcomes in the EudraVigilance Database
por: Mansour Tobaiqy, et al.
Publicado: (2021)

Treatment-Related Adverse Events with PD-1 or PD-L1 Inhibitors: A Systematic Review and Meta-Analysis
por: Yixi Zhang, et al.
Publicado: (2021)

Assessing the value of preoperative medical clearance in patients with primary rhegmatogenous retinal detachment
por: Alabi RO, et al.
Publicado: (2019)

COVID-19 vaccine safety monitoring in the Republic of Korea: February 26, 2021 to April 30, 2021
por: Hyun-kyung Oh, et al.
Publicado: (2021)

Evaluation of the Health Assessment Questionnaire Disability Index in Chilean patients with rheumatoid arthritis
por: Durán,Josefina, et al.
Publicado: (2019)

Time Trends in Patient Characteristics and In-Hospital Adverse Events for Primary Total Knee Arthroplasty in the United States: 2010-2017
por: Mohamad J. Halawi, MD, et al.
Publicado: (2021)

Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems
por: Han N, et al.
Publicado: (2021)

Prevalence of depression among Iranian patients with rheumatoid arthritis: a systematic review and meta-analysis
por: Jamshidi T, et al.
Publicado: (2019)

Rheumatic Manifestations and Diseases From Immune Checkpoint Inhibitors in Cancer Immunotherapy
por: Pan Shen, et al.
Publicado: (2021)

Correlations between immunogenicity, drug levels, and disease activity in an Italian cohort of rheumatoid arthritis patients treated with tocilizumab
por: Benucci M, et al.
Publicado: (2016)

EFFICACY AND SAFETY OF SIMVASTATIN IN RHEUMATOID ARTHRITIS: AN OPEN-LABEL, CONTROLLED STUDY
por: I. V. Shirinsky, et al.
Publicado: (2014)

MONITORING OF DRUG SAFETY IN CLINICAL PRACTICE
por: N. V. Verlan, et al.
Publicado: (2017)

Polypharmacy Management in the Older Adults: A Scoping Review of Available Interventions
por: M. Kurczewska-Michalak, et al.
Publicado: (2021)

Regulation Awareness and Experience of Additional Monitoring among Healthcare Professionals in Finland
por: Andreas Sandberg, et al.
Publicado: (2021)

TDZD-8 Suppresses Rheumatoid Arthritis Induced by Collagen Type II in Rats: Potential Role of Apoptosis and Inflammation
por: Dawood,Amal F
Publicado: (2021)

Work instability and associated factors among patients with rheumatoid arthritis in Greater Poland
por: Wiktor Schmidt, et al.
Publicado: (2020)

Etiology and Risk Factors for Rheumatoid Arthritis: A State-of-the-Art Review
por: Vasco C. Romão, et al.
Publicado: (2021)

Inappropriate prescribing in the hospitalized elderly patient: Defining the problem, evaluation tools, and possible solutions
por: Robert L Page II, et al.
Publicado: (2010)

Anti-Angiogenesis Maintenance Therapy in Newly Diagnosed and Relapsed Ovarian Cancer: A Meta-analysis of Phase III Randomized Controlled Trials
por: Yizi Wang, et al.
Publicado: (2021)

Bifocal Distraction in Patient with Rheumatoid Arthritis and Severe Condylar Degeneration: Report of Case
por: Chaves Neto,Henrique Duque de Miranda, et al.
Publicado: (2011)